Codexis, Inc. (CDXS) Stock Analysis

Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?

Fri, August 14, 2026 at 4:00 PM UTC 3 min read

Codexis (CDXS) has been upgraded to a "Buy" rating by analysts, signaling increased confidence in the company's growth potential and financial performance. This upgrade may attract more investors, potentially driving up the stock price as market sentiment shifts positively. For current and prospective shareholders, this could indicate a favorable opportunity for investment in the biotechnology sector.

Read full article →

Codexis Inc (CDXS) (Q2 2026) Earnings Call Highlights: Biocatalysis Growth and ECO Synthesis ...

Wed, August 12, 2026 at 5:02 AM UTC 3 min read

Codexis Inc (CDXS) reported strong growth in biocatalysis during its Q2 2026 earnings call, highlighting advancements in ECO synthesis technology. This growth is significant for investors as it underscores the company's expanding market presence and potential for increased revenue streams in sustainable manufacturing solutions. The positive outlook on biocatalysis positions CDXS favorably within the biotech sector, suggesting potential long-term value for shareholders.

Read full article →